Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Zetia Legal News Articles & Interviews

Zetia and Vytorin Continue to be Controversial

Zetia and Vytorin Continue to be Controversial August 28, 2017. By Gordon Gibb.
Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects, issues involving Zetia and its cousin Vytorin (Zetia in combination with a statin) continue to lazily percolate like water at a gentle boil.
Read [ Zetia and Vytorin Continue to be Controversial ]

Vytorin Has a Complex History

Vytorin Has a Complex History May 15, 2015. By Heidi Turner.
Washington, DC The new study on Vytorin may be out, and it may signal good news for its drug maker, but as far back as 2008, there were serious concerns about how Merck and Schering-Plough planned to study potential Vytorin side effects. Concerns were so high that on March 31, 2008, Senator Chuck Grassley sent a letter to Merck and Schering-Plough outlining his worries.
Read [ Vytorin Has a Complex History ]

Merck Pushes Positive Vytorin Results

Merck Pushes Positive Vytorin Results April 15, 2015. By Heidi Turner.
San Diego, CA As more information on a recent Vytorin study is released, Merck has continued to tout the positive findings of that study. Vytorin side effects have been at the heart of Vytorin lawsuits, alleging patients were put at risk of health problems due to their use of the drug.
Read [ Merck Pushes Positive Vytorin Results ]

Vytorin Brightens with IMPROVE-IT, but Vytorin Lawsuits Remain

Vytorin Brightens with IMPROVE-IT, but Vytorin Lawsuits Remain March 27, 2015. By Gordon Gibb.
San Diego, CA The folks at Merck & Co. and their Vytorin partner Schering-Plough Corp. can be forgiven if they are enjoying the re-birth of Vytorin and the accompanying optimism after enduring the scorn that accompanied the delayed release of the ENHANCE study in 2008. The most recent “IMPROVE-IT” study was designed to foster a better outcome, and the study delivered. The future of Vytorin is much rosier. However, questions surrounding Vytorin side effects remain. And many a Vytorin lawsuit stemming from the two-year delay in releasing the ENHANCE results continues to hang over Merck’s head.
Read [ Vytorin Brightens with IMPROVE-IT, but Vytorin Lawsuits Remain ]

Study Finds Benefit to Vytorin, but Is It Credible?

Study Finds Benefit to Vytorin, but Is It Credible? November 20, 2014. By Heidi Turner.
Chicago, IL A study released today suggests that Vytorin, a drug that combines Zetia and Zocor, is more effective than Zetia alone at preventing heart attack and other heart-related health problems. The study is good news for Merck, who has been under fire for its handling of Vytorin. But other previous studies gave conflicting results regarding Vytorin’s effectiveness, and there are concerns about the delays in releasing this study, including a switch in primary endpoints, which could affect how positive the results actually are.
Read [ Study Finds Benefit to Vytorin, but Is It Credible? ]

Medical Industry Waits for Study on Vytorin

Medical Industry Waits for Study on Vytorin October 29, 2014. By Heidi Turner.
Washington, DC Less than a month away is the expected deadline for the medical world to hear the results of a study on Vytorin. The study has been undertaken to add to the published literature about Vytorin side effects and Vytorin effectiveness. So far, at least two studies regarding the drug, which combines ezetimibe (Zetia) and simvastatin (Zocor), have not shown that Vytorin is any more effective than Zocor alone.
Read [ Medical Industry Waits for Study on Vytorin ]

New Vytorin Study Results on the Way

New Vytorin Study Results on the Way September 27, 2014. By Heidi Turner.
Washington, DC Another study is set to be released regarding the effectiveness of Vytorin, a drug that combines ezetimibe (known by the brand name Zetia) and simvastatin (known by the brand name Zocor). Whether the study will confirm previous findings that question the effectiveness of combining Zetia and Zocor is not known. Some previous studies have failed to show that the two drugs combined are more effective than Zocor alone or Zocor and a different statin.
Read [ New Vytorin Study Results on the Way ]

Of All Vytorin Side Effects, Potential for Cancer Is Getting Traction

Of All Vytorin Side Effects, Potential for Cancer Is Getting Traction August 31, 2014. By Gordon Gibb.
Washington, DC One can’t help but forgive anyone filing a Vytorin lawsuit, due to not only the potential for various harms related to possible Vytorin side effects, but to the very culture that sees drugs such as these approved in the first place.
Read [ Of All Vytorin Side Effects, Potential for Cancer Is Getting Traction ]

Critics Question Liptruzet

Critics Question Liptruzet May 5, 2013. By Heidi Turner.
Washington, DC Even though Liptruzet has only just been introduced on the market, at least one critic is questioning why the drug received approval. Liptruzet is a combination of Lipitor and Zetia, but Steven Nissen, of the Cleveland Clinic, says that because Zetia has not been proven to prevent heart attacks and strokes, approving it in combination with another drug does not make sense.
Read [ Critics Question Liptruzet ]

Zetia and/or Statins: The Good, the Bad and the Ugly

Zetia and/or Statins: The Good, the Bad and the Ugly April 14, 2011. By Gordon Gibb.
Halle-Wittenberg, Germany Can a drug designed to curb heart attacks also cause heart attacks in some people? Apparently, it's possible with statins or medication like Zetia when used in combination with a statin. Statins are designed to lower the "bad" cholesterol thought to be a contributing factor for heart attack and stroke, while leaving the so-called "good" cholesterol to do the good work that good cholesterol, ultimately, does.
Read [ Zetia and/or Statins: The Good, the Bad and the Ugly ]


Request Legal Help Now! - Free